Effect of Discharge Via an Intermediate Care Unit

NCT ID: NCT01706744

Last Updated: 2015-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

328 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal is to investigate the following topics:

1. Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital?
2. Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital?
3. Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients Aged

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intermediate care unit

Follow-up treatment and care in a intermediate care unit after discharge from hospital

Group Type EXPERIMENTAL

Intermediate care unit

Intervention Type OTHER

Local health care 1

Discharge from hospital to usual care as provided by the local health and social care (Verdal)

Group Type ACTIVE_COMPARATOR

Local health care 1

Intervention Type OTHER

Local health care 2

Discharge from hospital to usual care as provided by the local health and social care (Stjørdal)

Group Type ACTIVE_COMPARATOR

Local health care 2

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intermediate care unit

Intervention Type OTHER

Local health care 1

Intervention Type OTHER

Local health care 2

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients 60 years old or older from Stjørdal- or Verdal municipality,

* given consent,
* admitted from their home,
* diagnostics completed and necessary treatment started
* the patient need not less than 3-4 days institutionalization for treatment/rehabilitation/care

Exclusion Criteria

* Patients with severe dementia
* Patients with severe disease who cannot give consent
* Patients with severe disease with short life expectancy (including severe cancer)
Minimum Eligible Age

60 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roar Johnsen, PhD

Role: STUDY_DIRECTOR

Norwegian University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sykehuset Levanger

Levanger, , Norway

Site Status

Distriksmedisinsk Senter

Stjørdal, , Norway

Site Status

Stjørdal Kommune

Stjørdal, , Norway

Site Status

Verdal kommune

Verdal, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Dahl U, Johnsen R, Saetre R, Steinsbekk A. The influence of an intermediate care hospital on health care utilization among elderly patients--a retrospective comparative cohort study. BMC Health Serv Res. 2015 Feb 1;15:48. doi: 10.1186/s12913-015-0708-4.

Reference Type RESULT
PMID: 25638151 (View on PubMed)

Dahl U, Steinsbekk A, Jenssen S, Johnsen R. Hospital discharge of elderly patients to primary health care, with and without an intermediate care hospital - a qualitative study of health professionals' experiences. Int J Integr Care. 2014 Apr 30;14:e011. doi: 10.5334/ijic.1156. eCollection 2014 Apr.

Reference Type RESULT
PMID: 24868194 (View on PubMed)

Dahl U, Steinsbekk A, Johnsen R. Effectiveness of an intermediate care hospital on readmissions, mortality, activities of daily living and use of health care services among hospitalized adults aged 60 years and older--a controlled observational study. BMC Health Serv Res. 2015 Aug 28;15:351. doi: 10.1186/s12913-015-1022-x.

Reference Type RESULT
PMID: 26315779 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009/1697

Identifier Type: -

Identifier Source: org_study_id